BLS Pharma

BLS Pharma is a small private pharmaceutical company that appears to have been developing a drug-device combination for testosterone replacement therapy. Publicly available information on the company is sparse, but court filings and related press coverage identify BLS Pharma as a Delaware corporation headquartered in Lake Forest, California and focused on a needle-free testosterone product. The company’s disclosed development focus was testosterone replacement for male hypogonadism and potentially for transgender men requiring lifelong hormone therapy. There is no clear evidence of an active broader pipeline, approved products, public financing history, or commercial operations. Based on the limited record, BLS Pharma looks like an early-stage, narrowly focused private healthcare company rather than a diversified biotech platform business.